Skip to main content
Clinical Trials/NL-OMON50463
NL-OMON50463CompletedPhase 3

Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer - Physical Activity & Memory (PAM) study

niversitair Medisch Centrum0 sites180 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
180

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Inclusion criteria for the study are: breast cancer patients adjuvantly treated
  • with chemotherapy plus or minus endocrine therapy, 2-4 years after cancer
  • diagnosis, 30-75 years of age, no indication of relapse or metastases, exercise
  • * 150 min/week self-reported cognitive problems, lower than expected
  • performance on neuropsychological testing, mastering the Dutch language and
  • willing to be randomly assigned to one of the two study arms.

Exclusion Criteria

  • We will exclude patients with known neurological conditions and/or diseases
  • that affect cognition (e.g. dementia, MS, TBI), disorders that might impede
  • exercise participation, patients with breast cancer in both breasts, contra
  • indications for MR imaging (see Appendix 2 Protocol); and patients switching
  • from Tamoxifen to aromatase inhibitors during the study period or four months

Investigators

Sponsor
niversitair Medisch Centrum

Similar Trials